glp 1 with 3 receptors Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Trends in the Development of

This product does not work like prescription GLP-1 medications, does not contain GLP-1 compounds, and has not demonstrated comparable effects

Circulating glutathione peroxidase and superoxide dismutase levels in patients with epilepsy: A meta-analysis

10.1097/00001504-200503000-00005 23 CaspiA.MoffittT

Moreover, diabetes is very costly from an economic perspective: by 2021, global diabetes healthcare costs were over $966 billion, and this is expected to surpass $1 trillion according to estimates from the Global Burden of Disease study by 2045 [1], [2]

The total extract of MO was cheap and effective which has saved a large number of patients in the less developed area of the world